Activatable Polypeptides for Lipid Vesicle Permeability Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Cytolytic peptides used in diagnostic methods face challenges due to inferior sensitivity and non-specific variable backgrounds, with issues related to the stability and controlled release of marker molecules from liposomes, leading to background interference and unreliable assays.

Innovation Solution

Development of polypeptides with activatable groups that modulate lipid vesicle permeability in response to environmental stimuli, such as pH changes or enzymatic activation, allowing for controlled release of substances and improved diagnostic accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If cytolytic peptides are used to release marker molecules from liposomes in diagnostic assays, then the detection capability is improved, but background signal interference increases due to progressive release of marker molecules

Engineering Contradiction:
Improvedetection capabilityVSAvoidbackground signal interference
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The cytolytic peptide is designed in an inactive precursor form that requires specific activation conditions (pH change, enzyme treatment) to become active. This preliminary inactive state prevents background signal interference during assay storage and handling, while activation only occurs when the target microorganism is present and metabolic conditions are favorable, thereby improving detection specificity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The peptide's cytolytic activity is made dynamic and condition-dependent rather than constant. The peptide transitions between inactive and active states based on environmental conditions (pH, enzyme presence), allowing controlled release of marker molecules only when activation conditions are met, thus reducing background interference while maintaining detection capability.

Inventive Principle:
Principle #15Dynamics

2Productivity

If cytolytic peptides are used to modulate lipid vesicle permeability, then the release of marker molecules is achieved, but the stability and water solubility of the peptides deteriorate

Engineering Contradiction:
Improvemarker molecule releaseVSAvoidpeptide stability and water solubility
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The peptide sequence and chemical modifications are optimized to change physical parameters (amphipathic structure, charge distribution, hydrophilicity) to enhance water solubility and stability while maintaining cytolytic activity. Specific amino acid residues are selected and positioned to balance membrane permeability modulation capability with aqueous stability, preventing premature aggregation or degradation.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If conventional cytolytic peptides are used in diagnostic methods, then the assay can be performed, but sensitivity and specificity deteriorate due to non-specific variable background

Engineering Contradiction:
Improveassay performabilityVSAvoidsensitivity and specificity
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

A control peptide or reference substance is introduced as an intermediary element in the assay system. This control peptide exhibits similar properties to the test peptide but serves as a reference for background signal levels, allowing differentiation between specific and non-specific responses. The control helps normalize the assay and improve specificity by accounting for variable background conditions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of these polypeptides enables precise and reliable detection of target microorganisms by minimizing background signal interference and ensuring controlled release of marker molecules, enhancing the sensitivity and specificity of diagnostic assays.

Implementation Method 1

The polypeptide can comprise an activatable pore-forming portion which, when activated modulates the permeability of the lipid vesicle

Methodology Applied
Scientific EffectPore formation:

Implementation Method 2

The hydrolysis of at least one of the phosphate groups can activate the pore-forming portion of the polypeptide

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS8936916B2Polypeptides for microbial detection
Publication Date: 2015.01.20 NEOGEN FOOD SAFETY US HOLDCO CORP
  • US8936916B2 patent drawing
  • US8936916B2 patent drawing
  • US8936916B2 patent drawing

AI summary

Polypeptides which can be activated to cause the formation of pores in a lipid membrane are disclosed. Also disclosed are polypeptide compositions for the detection of target microorganisms and methods of using said compositions.